Performance Evaluation of Five Real-Time PCR Assays for the Detection of Candida auris DNA

被引:0
作者
Buil, Jochem B. [1 ,2 ]
van den Bosch, Bart [1 ,2 ]
van der Maas, Suzan J. [1 ]
Meijer, Eelco F. J. [2 ,3 ]
de Groot, Theun [2 ,3 ]
Meletiadis, Joseph [4 ,5 ,6 ]
Verweij, Paul E. [1 ,2 ,7 ]
Melchers, Willem J. G. [1 ,2 ]
Pas, Suzan D. [1 ,2 ]
机构
[1] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands
[2] Radboudumc CWZ, Ctr Expertise Mycol, Nijmegen, Netherlands
[3] Canisius Wilhelmina Hosp Dicoon, Dept Med Microbiol & Immunol, Nijmegen, Netherlands
[4] Attikon Univ Hosp, Natl & Kapodistrian Univ Athens, Med Sch, Clin Microbiol Lab, Athens, Greece
[5] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands
[6] Statens Serum Inst, Unit Mycol, Copenhagen, Denmark
[7] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diag & Lab Surveillance, Bilthoven, Netherlands
关键词
Candida; Candida spp; PCR; CLONAL STRAIN;
D O I
10.1111/myc.70065
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
ObjectivesThis study aimed to systematically evaluate and compare the performance of two laboratory-developed assays (LDAs) and three commercially available real-time PCR assays for the detection of Candida auris. The analytical sensitivity, specificity and limit of detection (LOD) of each assay were assessed, alongside their clinical sensitivity in identifying C. auris colonisation.MethodsTen C. auris strains representing five clades, as well as genetically related yeasts, common yeast species, and dermatophytes, were used to assess assay sensitivity and cross reactivity. Clinical and environmental samples were collected from patients during an outbreak and tested with three commercial PCR assays (AurisID, Fungiplex, FungiXpert) and two LDAs (CDC LDA, EMC LDA). LOD was determined using Probit analysis. Diagnostic sensitivity was evaluated by comparing the detection rate of each individual assay to the total detection rate of all assays combined.ResultsThe EMC LDA exhibited the highest analytical sensitivity, with a LOD of 8 conidia/reaction, followed by CDC LDA (16 conidia/reaction), AurisID and FungiXpert (19 conidia/reaction), and Fungiplex (596 conidia/reaction). Specificity testing revealed cross-reactivity in the CDC LDA and AurisID assays with C. pseudohaemulonii at high conidia levels, while no cross-reactivity was observed in the other assays. EMC LDA showed the highest clinical sensitivity (100%), whereas Fungiplex had the lowest positivity rate (71%). No false positives were observed in negative control swabs for any assay.ConclusionsReal-time PCR is a crucial tool for the rapid and sensitive detection of C. auris , especially in clinical settings where timely identification is essential for effective patient management and infection control. Numerous PCR assays are available for this purpose; however, our study demonstrates that the sensitivity of these assays can vary significantly. The observed differences underscore the importance of establishing international reference standards and proficiency panels to enhance the accuracy and comparability of assay performance across different studies and laboratories.
引用
收藏
页数:8
相关论文
共 19 条
[1]   Candida auris in Healthcare Facilities, New York, USA, 2013-2017 [J].
Adams, Eleanor ;
Quinn, Monica ;
Tsay, Sharon ;
Poirot, Eugenie ;
Chaturvedi, Sudha ;
Southwick, Karen ;
Greenko, Jane ;
Fernandez, Rafael ;
Kallen, Alex ;
Vallabhaneni, Snigdha ;
Haley, Valerie ;
Hutton, Brad ;
Blog, Debra ;
Lutterloh, Emily ;
Zucker, Howard .
EMERGING INFECTIOUS DISEASES, 2018, 24 (10) :1816-1824
[2]   Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities [J].
Ahmad, Suhail ;
Alfouzan, Wadha .
MICROORGANISMS, 2021, 9 (04)
[3]   Tools and techniques to identify, study, and control Candida auris [J].
Carty, James ;
Chowdhary, Anuradha ;
Bernstein, Douglas ;
Thangamani, Shankar .
PLOS PATHOGENS, 2023, 19 (10)
[4]   Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses [J].
Chow, Nancy A. ;
Munoz, Jose F. ;
Gade, Lalitha ;
Berkow, Elizabeth L. ;
Li, Xiao ;
Welsh, Rory M. ;
Forsberg, Kaitlin ;
Lockhart, Shawn R. ;
Adam, Rodney ;
Alanio, Alexandre ;
Alastruey-Izquierdo, Ana ;
Althawadi, Sahar ;
Arauz, Ana Belen ;
Ben-Ami, Ronen ;
Bharat, Amrita ;
Calvo, Belinda ;
Desnos-Ollivier, Marie ;
Escandon, Patricia ;
Gardam, Dianne ;
Gunturu, Revathi ;
Heath, Christopher H. ;
Kurzai, Oliver ;
Martin, Ronny ;
Litvintseva, Anastasia P. ;
Cuomo, Christina A. .
MBIO, 2020, 11 (02)
[5]   Potential Fifth Clade of Candida auris, Iran, 2018 [J].
Chow, Nancy A. ;
de Groot, Theun ;
Badali, Hamid ;
Abastabar, Mahdi ;
Chiller, Tom M. ;
Meis, Jacques F. .
EMERGING INFECTIOUS DISEASES, 2019, 25 (09) :1780-1781
[6]   Multidrug-resistant endemic clonal strain of Candida auris in India [J].
Chowdhary, A. ;
Kumar, V. Anil ;
Sharma, C. ;
Prakash, A. ;
Agarwal, K. ;
Babu, R. ;
Dinesh, K. R. ;
Karim, S. ;
Singh, S. K. ;
Hagen, F. ;
Meis, J. F. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (06) :919-926
[7]   Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally [J].
Chowdhary, Anuradha ;
Sharma, Cheshta ;
Meis, Jacques F. .
PLOS PATHOGENS, 2017, 13 (05)
[8]   New Clonal Strain of Candida auris, Delhi, India [J].
Chowdhary, Anuradha ;
Sharma, Cheshta ;
Duggal, Shalini ;
Agarwal, Kshitij ;
Prakash, Anupam ;
Singh, Pradeep Kumar ;
Jain, Sarika ;
Kathuria, Shallu ;
Randhawa, Harbans S. ;
Hagen, Ferry ;
Meis, Jacques F. .
EMERGING INFECTIOUS DISEASES, 2013, 19 (10) :1670-1673
[9]   Development and Validation of a Real-Time PCR Assay for Rapid Detection of Candida auris from Surveillance Samples [J].
Leach, L. ;
Zhu, Y. ;
Chaturvedi, S. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (02)
[10]   Proposal for a screening protocol for Candida auris colonization [J].
Leonhard, S. E. ;
Chong, G. M. ;
Foudraine, D. E. ;
Bode, L. G. M. ;
Croughs, P. ;
Popping, S. ;
Schaftenaar, E. ;
Klaassen, C. H. W. ;
Severin, J. A. .
JOURNAL OF HOSPITAL INFECTION, 2024, 146 :31-36